India’s 1st Covid-19 Vaccine Allowed For Human Trial; Recovery Rate Swells To 60%

India's 1st Covid-19 Vaccine Allowed For Human Trial; Recovery Rate Swells To 60%
India’s 1st Covid-19 Vaccine Allowed For Human Trial; Recovery Rate Swells To 60%

On Monday, India’s drug regulatory authority flashed a green signal to Bharat Biotech’s COVID-19 vaccine for human trials, hence it became the first domestic candidate from the country as the COVID-19 cases soared to 565,000 in India.

Human Trials Will Start In July

 Further, the Drug Controller General of India has approved the company’s application to conduct a Phase I and II clinical trial of Covaxin.

 According to the company, they have developed this vaccine along with the Indian Council of Medical Research’s National Institute of Virology which was developed and manufactured in Bharat Biotech’s facility at Genome Valley in Hyderabad, India.

Moreover, the human clinical trials are scheduled to start across the country in July for the vaccine.

As per the data provided from the country’s federal Health Ministry, the country now lags only the United States, Brazil and Russia in total cases, reported close to 20,000 new infections on Monday.

So far, more than 16,000 people have died from the disease since the first case in India in January.

Which is lower when compared to countries with similar numbers of cases. 

However, experts fear  that hospitals in the densely populated nation will be unable to cope with a steep rise in cases.

So far, no vaccine has been approved for commercial use against the illness caused by the new coronavirus.

Although, currently, more than a dozen vaccines from over hundreds of candidates globally are being tested in humans.

On the other hand, China’s military received the approval to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy, the company said on Monday.

Covid-19 Recovery Rate India

As per the reports, India’s coronavirus recovery rate reached to 60% and more than 1 lakh 20 thousand COVID-19 infected persons have successfully recovered from this deadly infection. 

So far, there are 1,19,696 more recovered patients than active COVID-19 cases in the country, according to the Health Ministry.

Currently, there are 2,15,125 active cases, all under active medical supervision, out of that, 3,34,821 patients have been cured/discharged. 

Which finally resulted in the recovery rate amongst COVID-19 patients further improving to 59.07%, as per the Health Ministry. 

They further informed that, in the last 24 hours, a total of 13,099 COVID-19 patients have been cured across the country. 

Apart from that, the number of diagnostic labs has also gone up significantly, due to continuous efforts from the Centre and the state governments.

"India's 1st Covid-19 Vaccine Allowed For Human Trial; Recovery Rate Swells To 60%", 5 out of 5 based on 1 ratings.

Comments are closed, but trackbacks and pingbacks are open.

who's online